Back

Efficiency of guideline-directed medical therapy in patients with acute decompensated heart failure and subclinical congestion at discharge.

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy (4) Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Nutsiko Khutsishvili

Tbilisi (Georgia)

6 More presentations in this session

Presentation thumbnail
The spot urinary sodium determination in short-term decongestion therapy
Doctor A. Georgakopoulos (Veria, GR)
Abstract Slides Video
Presentation thumbnail
Patient-dependent factors limiting guideline-directed medical therapy in patients with heart failure with reduced left ventricular ejection fraction undergoing scheduled hospitalization
Doctor A. Galas (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Implementation of recommendations regarding pharmacotherapy optimization in patients with heart failure undergoing scheduled hospitalization - the HEROES study.
Doctor A. Galas (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Reasons for underutilization of medical therapy for heart failure with reduced ejection fraction
Doctor K. Berge (Nordbyhagen, NO)
Abstract Slides Video
Presentation thumbnail
Design and rationale of a phase 3 study to evaluate the efficacy and safety of nucresiran (ALN-TTRsc04) in patients with transthyretin amyloidosis with cardiomyopathy
Professor M. Fontana (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy (4)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Effect of improving utilization of guideline-directed medical therapy for heart failure.
thumbnail
Congress Presentation
Use of guideline-directed therapy in patients hospitalised at a general internal medicine ward
thumbnail
Congress Presentation
Guideline directed medical therapy (GDMT) prescription after an admission for acute decompensated heart failure in Malaysia

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources